CVS Health Corp.

CVS

$110.60

+2.78%

N/A+$2.99

Healthcare

Medical - Healthcare Plans

NYSE

Active Trading

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: ...

Recent News of CVS

The Globe and Mail7/13/2026Somewhat-Bearish (-0.191)

U.S. appeals court revives more than 500 lawsuits against Tylenol-maker Kenvue over autism claims

A federal appeals court has revived over 500 lawsuits against Kenvue, the maker of Tylenol, concerning claims that the painkiller causes autism and ADHD in children when used during pregnancy. The court stated that a district judge improperly excluded expert testimony from three doctors who supported a link, although medical consensus generally views acetaminophen as safe for pregnancy. Kenvue maintains that Tylenol is safe and plans to challenge the reliability of the plaintiffs' experts again.

TradingView7/13/2026Somewhat-Bullish (0.271)

Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?

Humana aims for a 3% Medicare Advantage margin by 2028, shifting its focus from membership growth to profitability. The company plans to achieve this through disciplined pricing, improved product design, better retention, and tighter care management, despite current challenges like elevated healthcare utilization. Competitors like UnitedHealth Group and CVS Health also prioritize Medicare Advantage profitability, indicating an industry-wide trend towards margin improvement through similar strategies.

Yahoo Finance7/13/2026Somewhat-Bullish (0.256)

Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?

Humana (HUM) is targeting a 3% Medicare Advantage margin by 2028, shifting its focus from membership growth to profitability. The company plans to achieve this through disciplined pricing, improved product design, better member retention, and enhanced care management, despite elevated healthcare utilization and regulatory challenges. Peers like UnitedHealth Group (UNH) and CVS Health (CVS) are also implementing similar strategies to restore Medicare Advantage profitability.

CBIZ7/13/2026Neutral (0.113)

The Rx Bill of Goods That Was Never Delivered: Why Savings Fall Short

This article discusses the persistent problem employers face with pharmacy costs due to a lack of visibility into what they are paying for and why costs are increasing. It highlights the gap between promised savings in proposals and actual performance, the "rebate illusion" where high rebates don't always mean true savings, and the impact of new drugs like GLP-1s. The article emphasizes the importance of a proactive and informed approach to pharmacy strategy rather than a reactive one.

MarketBeat7/13/2026Neutral (0.035)

CVS Health (NYSE:CVS) Hits New 52-Week High After Dividend Announcement

CVS Health (NYSE:CVS) reached a new 52-week high after announcing a quarterly dividend of $0.665 per share. The company also reported strong quarterly earnings, beating expectations, and analysts maintain a "Moderate Buy" rating with an average price target of $103.64. Despite the positive performance, insider transactions reveal significant share sales over the last three months.

The Globe and Mail•7/13/2026

U.S. appeals court revives more than 500 lawsuits against Tylenol-maker Kenvue over autism claims

Somewhat-Bearish (-0.191)

life sciences

CVS: Neutral (-0.106)

Relevance 0.629

TradingView•7/13/2026

CVS Maintained by Wells Fargo -- Price Target Raised to $123

Wells Fargo has maintained an "Overweight" rating for CVS Health Corp, increasing its price target from $103.00 to $123.00, suggesting confidence in the company's future growth. Despite this positive analyst sentiment, GuruFocus indicates CVS is currently overvalued by 36.3% based on its GF Value™ of $77.70 versus its current price of $105.94. Additionally, significant insider selling totaling $323.7 million in the last three months warrants caution for investors.

CVS Health Corp.

Recent News of CVS

U.S. appeals court revives more than 500 lawsuits against Tylenol-maker Kenvue over autism claims

Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?

Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?

The Rx Bill of Goods That Was Never Delivered: Why Savings Fall Short

CVS Health (NYSE:CVS) Hits New 52-Week High After Dividend Announcement

U.S. appeals court revives more than 500 lawsuits against Tylenol-maker Kenvue over autism claims

Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?

Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?

The Rx Bill of Goods That Was Never Delivered: Why Savings Fall Short

CVS Health (NYSE:CVS) Hits New 52-Week High After Dividend Announcement

CVS Maintained by Wells Fargo -- Price Target Raised to $123

CVS Health stock hits 52-week high at 106.16 USD By Investing.com

CVS Health stock hits 52-week high at 106.16 USD

CLCV ETF Holdings List — AMEX:CLCV

Tonix Pharmaceuticals Adds Medicare Part D Coverage for TONMYA, Expands Sales Force

Jim Cramer Says “Buy the Stock of CVS, I Sure Wish I’d Done It for My Trust”

Teachers Retirement System of The State of Kentucky Grows Stock Holdings in CVS Health Corporation $CVS

LGT Fund Management Co Ltd. Makes New Investment in CVS Health Corporation $CVS

Summit Securities Group LLC Has $72,000 Stock Position in CVS Health Corporation $CVS

CVS Health Corporation $CVS Position Boosted by Elevated Capital Advisors LLC

CVS Health stock holds steady on its pharmacy scale

CVS Health Corporation Plans Quarterly Dividend of $0.67 (NYSE:CVS)

CVS Health Corp. stock outperforms competitors on strong trading day

DVA|DaVita Inc|Price:232.800|Chg%:+3.260

Brookdale Senior Q2'26 Sneak Peek: Occupancy Volume Rises to 82.4%

What to Expect From CVS Health's Q2 2026 Earnings Report

CVS Health declares quarterly dividend of $0.665 per share

Sam’s Club, Weight Watchers Team Up On Weight Health Programs

CVS Health declares quarterly dividend of $0.665 per share By Investing.com

CVS Health schedules Aug. 3 payout for $0.665 dividend

Inside medtech’s cameo run on HBO Max’s ‘The Pitt’

Sumitomo Mitsui Trust Group Inc. Decreases Stock Holdings in CVS Health Corporation $CVS

Kroger walks back its cage-free egg pledge | Exclusive

CVS Health Corp. stock underperforms Thursday when compared to competitors

CVS Price Today: CVS HEALTH CORPORATION Stock Price, Quote & Chart

Aetna provides $300K to Christian Hospital Foundation to support food pharmacy program

DaVita Inc focus on kidney care operations as investors watch US healthcare demand

Sam’s Club members get free Weight Watchers trial, up to 50% off

CVS Health Corp. balances retail pressures and healthcare growth

HCA Healthcare, Inc. (NYSE:HCA) Receives Consensus Rating of "Moderate Buy" from Brokerages

Data-Focused Board Hire and Index Shift Could Be A Game Changer For Choice Hotels (CHH)

Alignment faces whistleblower lawsuit over accounting claims

CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It

Did Cigna's (CI) US$100 Million AI Pharmacy Bet Just Rewire Its Specialty-Care Narrative?

CVS Health Corp. focuses on pharmacy and health services as investors watch long-term strategy

UnitedHealthcare Medicare Supplement Insurance from UnitedHealth Group - steady coverage for US seni

Up 14.81% in a Year, COWZ Proves You Don’t Need Apple

CVS Health Corp. stock outperforms competitors on strong trading day

CVS Health outlook and strategy as a diversified U.S. healthcare player

CVS Health (NYSE:CVS) Upgraded at Wall Street Zen

Burney Co. Reduces Stock Position in CVS Health Corporation $CVS

UnitedHealth says most home-health diagnoses were supported in 2025

Cantor Fitzgerald raises CVS Health stock price target on margins

CVS Health: Thank You! Mews at St. Mary Affordable Housing Grand Opening - Williamstown, New Jersey

CVS Health’s SWOT analysis: stock faces margin recovery test